Levobunolol Hydrochloride
Product Code
TRC-L335000
CAS Number
Product Format
Neat
Molecular Formula
C17 H25 N O3 . Cl H
Molecular Weight
327.85
API Family
Levobunolol HydrochlorideProduct Categories
Pharmaceutical Reference Standards, TRC, Chiral Molecules , Anticonvulsants / Antiepileptics, Bioactive small molecules, API Reference Standards & Research Materials, Enzyme agonists & antagonists
Product Type
APIAlternate CAS Number
Purity
>95% (HPLC)
Documentation
Looking for another lot?
To view all certificates of analysis immediately, please login to your account
or
{{ errors.first('lotNumber') }}
{{ errors.first('requestEmail') }}
For information about our data processing activities, please visit our Privacy Notice.
Enter your email address and we'll email you the relevant CoA for lots:
{{ coaPopupData.packSize.coaSelectedLotNumbers }}
{{ errors.first('coaEmail') }}
We will be sending the CoA to your email address {{ coaEmailPopupData.userEmail }}
Your request has been sent to our sales team to process.
Find an SDS for your region
{{ errors.first('selectedRegion') }}
{{ errors.first('sdsEmail') }}
For information about our data processing activities, please visit our Privacy Notice.
Your request has been sent to our sales team to process.
Product Information
Chemical Data
Analyte Name
Levobunolol, Hydrochloride
CAS Number
27912-14-7
Molecular Formula
C17 H25 N O3 . Cl H
Molecular Weight
327.85
Accurate Mass
327.1601
Flash Point
4
SMILES
Cl.CC(C)(C)NC[C@H](O)COc1cccc2C(=O)CCCc12
InChI
/m0./s1, InChI=1S/C17H25NO3.ClH/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20, /h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3, 1H/t12-
IUPAC
5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one;hydrochloride
Alternate CAS Number
Free base: 47141-42-4
Product Data
Storage Temperature
+4°C
Shipping Temperature
Room Temperature
Country of Origin
CANADA
Product Type
API
Product Format
Neat
API Family
Purity
>95% (HPLC)
Product Description
A non-selective +?-adrenoceptor antagonist used as an anticonvulsant.
References: Kaplan, H.R., et al.: Eur. J. Pharm., 16, 237 (1971), DiCarlo,F.J., et al.: Clin. Pharm. Ther., 22, 858 (1977)